Carmot Therapeutics, Inc. announces Michael Gray as Chief Financial Officer
Carmot Therapeutics, Inc. announced the appointment of Michael Gray as Chief Financial Officer.
Michael Gray most recently served as CFO and COO at Imara, Inc. With nearly 20 years of leadership experience, he brings extensive strategic, financial, and operational expertise to Carmot. As CFO, Michael will oversee financial operations, corporate finance strategies, investor relations, and strategic initiatives.
Carmot Therapeutics, Inc. is a company dedicated to developing therapies for diabetes and obesity.